Worth reading
51Recurring
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
20
% (year-on-year change in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Third quarter1 October 2025 to 30 June 2026ConsolidatedJapanese GAAPNet Sales5,467¥ millionYear on year +10.0%Progress 80.7%
Operating profit1,063¥ millionYear on year +20.0%Progress 96.0%
Ordinary income1,058¥ millionYear on year +20.4%Progress 97.1%
Net income attributable to owners of the parent696¥ millionYear on year +20.8%Progress 96.9%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥199.25
Financial position at period-end
Total assets10,078¥ million
of which net assets 5,844 ¥ millionEquity ratio 58.0%vs. prior year-end +2.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueReal estate brokerage business ¥2,893,420 thousand (YoY +9.5%), Property Management Business ¥1,927,604 thousand (YoY +10.1%), Resident support business ¥646,654 thousand (YoY +11.7%)
Segment profitReal estate brokerage business ¥607,366 thousand (YoY +11.7%), Property Management Business ¥337,441 thousand (YoY +9.5%), Resident support business ¥371,184 thousand (YoY +10.8%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥6,778 million (YoY +6.2%)
Operating profit¥1,107 million (YoY +8.3%)
Ordinary income¥1,090 million (YoY +6.8%)
Net income¥718 million (YoY +2.7%)
Annual Dividend Forecast¥68 → ¥70
Factors Behind Changes in Business Performance
The factors were steady growth in each business segment, higher sales of real estate held for sale, and the effects of other cost reductions. Personnel expenses increased due to upfront investment in human resources, while advertising expenses, land and building rents, and other costs increased in connection with the opening of new stores and other initiatives.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 Yes見積りの変更 No修正再表示 No
Changes in the scope of consolidationNewly consolidated: 0 companies; excluded: 0 companies. There were no significant changes to the scope of consolidation during the period.
Material subsequent eventsAll shares of 株式会社共栄薬研 and its wholly owned subsidiary, 株式会社ライフライン, were acquired on 31 July 2026. The acquisition consideration was ¥450 million, and acquisition-related expenses were ¥7 million.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥2,394 thousand, Gain on sale of non-current assets ¥5,860 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥38 thousand
Depreciation and amortization¥99,183 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo (attendees: Not disclosed)
Issued Shares at Period-End3,520,800 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 June 2026 |
| Net Sales | ¥5,467 million (YoY +10.0%) |
| Operating profit | ¥1,063 million (YoY +20.0%) |
| Ordinary income | ¥1,058 million (YoY +20.4%) |
| Profit attributable to owners of the parent | ¥696 million (YoY +20.8%) |
| Net income per share | ¥199.25 |
| Equity ratio | End of the current fiscal period 58 / End of previous period 55.6 |
| Total assets | ¥10,078 million |
| Net assets | ¥5,844 million |
| Full-year earnings forecast | Net Sales ¥6,778 million (YoY +6.2%) / Operating profit ¥1,107 million (YoY +8.3%) / Ordinary income ¥1,090 million (YoY +6.8%) / Net income ¥718 million (YoY +2.7%) |
| Annual Dividend Forecast | ¥68 → ¥70 |
| Segment revenue | Real estate brokerage business ¥2,893,420 thousand (YoY +9.5%), Property Management Business ¥1,927,604 thousand (YoY +10.1%), Resident support business ¥646,654 thousand (YoY +11.7%) |
| Segment profit | Real estate brokerage business ¥607,366 thousand (YoY +11.7%), Property Management Business ¥337,441 thousand (YoY +9.5%), Resident support business ¥371,184 thousand (YoY +10.8%) |
| Depreciation and amortization | ¥99,183 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥2,394 thousand, Gain on sale of non-current assets ¥5,860 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥38 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes Yes / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Newly consolidated: 0 companies; excluded: 0 companies. There were no significant changes to the scope of consolidation during the period. |
| Material subsequent events | All shares of 株式会社共栄薬研 and its wholly owned subsidiary, 株式会社ライフライン, were acquired on 31 July 2026. The acquisition consideration was ¥450 million, and acquisition-related expenses were ¥7 million. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No (attendees: Not disclosed) |
| Issued Shares at Period-End | 3,520,800 Shares |
| Factors Behind Changes in Business Performance | The factors were steady growth in each business segment, higher sales of real estate held for sale, and the effects of other cost reductions. Personnel expenses increased due to upfront investment in human resources, while advertising expenses, land and building rents, and other costs increased in connection with the opening of new stores and other initiatives. |
Items this document does not state (12)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment lossTreasury Shares at Period-End
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The factors were the expansion of areas covered by the real estate leasing brokerage business, an increase in the number of properties managed by the real estate management business, the development of referral partners for the resident support business, higher sales of real estate held for sale, and the effects of other cost reductions. Personnel expenses, advertising expenses, land and building rents, and other costs increased.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.